IP Verse

Elan Pharma competitive analysis

Latest patents of Elan Pharma opposed by its competitors

Explore Elan Pharma's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Aug 27, 2026
Patent NumberPublication DateTitleTotal Oppositions
EP2645106
Oct 2, 2024Methods And Products For Evaluating An Immune Response To A Therapeutic Agent1
EP1872136
Feb 8, 2023Methods And Products For Evaluating An Immune Response To A Therapeutic Protein2
EP1578253
Sep 28, 2022Prevention And Treatment Of Synucleinopathic Disease1
EP1793855
Jan 19, 2022Prevention And Treatment Of Synucleinopathic And Amyloidogenic Disease1
EP1991267
Dec 20, 2017Methods Of Treating Inflammatory And Autoimmune Diseases With Natalizumab1
EP1910829
Mar 2, 2016Prevention And Treatment Of Synucleinopathic And Amyloidogenic Disease1
EP1734997
Sep 2, 2015Steroid Sparing Agents And Methods Of Using Same1
EP2336184
Dec 3, 2014Administration Of Agents For The Treatment Of Inflammation1
EP1827374
Nov 5, 2014Injectable Nanoparticulate Olanzapine Formulations1

Latest PTAB cases involving Elan Pharma

Discover the latest PTAB cases involving Elan Pharma, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Elan Pharma with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Aug 27, 2026
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
ELAN PHARMACEUTICALS - 9 - -
H LUNDBECK18 - -
MACLEAN1 - - -
PHARMACEUTICAL WORKS POLPHARMA SA6 - - -